Corbenic Partners LLC - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Corbenic Partners LLC ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$6,000
+100.0%
1,8110.0%0.00%
+100.0%
Q1 2021$3,000
+50.0%
1,8110.0%0.00%0.0%
Q4 2020$2,0000.0%1,8110.0%0.00%0.0%
Q3 2020$2,0000.0%1,8110.0%0.00%0.0%
Q2 2020$2,000
+100.0%
1,8110.0%0.00%0.0%
Q1 2020$1,000
-50.0%
1,8110.0%0.00%0.0%
Q4 2019$2,000
-71.4%
1,8110.0%0.00%
-88.9%
Q4 2017$7,000
+16.7%
1,8110.0%0.01%
+12.5%
Q3 2017$6,0001,8110.01%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Inspire Advisors, LLC 135,508$472,0000.15%
Wealth Advisory Solutions, LLC 156,850$546,0000.13%
Horst & Graben Wealth Management LLC 75,722$264,0000.07%
Miller Investment Management, LP 50,000$174,0000.03%
GSA CAPITAL PARTNERS LLP 44,655$155,0000.02%
Triton Wealth Management, PLLC 13,100$24,0000.01%
Renaissance Technologies 1,898,351$6,606,0000.01%
B. Riley Wealth Management, Inc. 19,000$66,0000.01%
Virtu Financial LLC 19,713$69,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 47,265$164,0000.01%
View complete list of CITIUS PHARMACEUTICALS INC shareholders